Mario Di Palma

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al. · The Lancet Oncology · 2017 · 589 citations

Medicine, Oncology, Pharmacology +15

Influence of weight loss on outcomes in patients with head and neck cancer undergoing concomitant chemoradiotherapy

Alessandra Grosso, Pier Carlo Gentile, Michèle Battista et al. · Head & Neck · 2007 · 243 citations

Medicine, Oncology, Radiation Oncology +17

Skeletal muscle density predicts prognosis in patients with metastatic renal cell carcinoma treated with targeted therapies

S. Antoun, Émilie Lanoy, Roberto Iacovelli et al. · Cancer · 2013 · 221 citations

Medicine, Oncology, Radiology +16

Prevalence and influence of malnutrition on quality of life and performance status in patients with locally advanced head and neck cancer before treatment

Pier Carlo Gentile, Federico Bianciardi, Michela Tosti et al. · Supportive Care in Cancer · 2009 · 192 citations

Medicine, Nutrition, Oncology +12

Phase II Trial of Consolidation Docetaxel and Samarium-153 in Patients With Bone Metastases From Castration-Resistant Prostate Cancer

Karim Fizazi, Philippe Beuzeboc, J. Lumbroso et al. · Journal of Clinical Oncology · 2009 · 173 citations · Full text

Medicine, Oncology, Pharmacotherapy +17